NasdaqGM - Delayed Quote USD
NewAmsterdam Pharma Company N.V. (NAMSW)
8.38
+0.38
+(4.75%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
864,620
347,097
478,497
67,686.42
Total Liabilities Net Minority Interest
107,120
58,704
48,431
11,312.02
Total Equity Gross Minority Interest
757,500
288,393
430,066
56,374.40
Total Capitalization
757,500
288,393
430,066
56,374.40
Common Stock Equity
757,500
288,393
430,066
56,374.40
Capital Lease Obligations
448
60
126
185.68
Net Tangible Assets
756,966
288,223
429,858
56,374.40
Working Capital
756,495
296,894
441,922
55,472.02
Invested Capital
757,500
288,393
430,066
56,374.40
Tangible Book Value
756,966
288,223
429,858
56,374.40
Total Debt
448
60
126
185.68
Share Issued
108,064.34
82,469.77
81,559.78
81,559.78
Ordinary Shares Number
108,064.34
82,469.77
81,559.78
81,559.78
12/31/2021 - 2/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
SNSE Sensei Biotherapeutics, Inc.
0.3701
+5.74%
NVCT Nuvectis Pharma, Inc.
10.41
+12.30%
PTCT PTC Therapeutics, Inc.
49.95
+3.65%
TVTX Travere Therapeutics, Inc.
16.70
+5.16%
TVGN Tevogen Bio Holdings Inc.
1.0200
+5.25%
CMRX Chimerix, Inc.
8.54
0.00%
CKPT Checkpoint Therapeutics, Inc.
4.0400
0.00%
RGLS Regulus Therapeutics Inc.
2.5500
+9.91%
QNRX Quoin Pharmaceuticals, Ltd.
6.56
+8.61%